Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemosensitivity in chronic heart failure.

P Ponikowski1, W Banasiak

  • 1Cardiology Department, Clinical Military Hospital, Wroclaw, Poland.

Heart Failure Monitor
|March 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel endotypes in heart failure: effects on guideline-directed medical therapy.

European heart journal·2018
Same author

Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study.

European heart journal·2017
Same author

Elevated troponin I level assessed by a new high-sensitive assay and the risk of poor outcomes in patients with acute heart failure.

International journal of cardiology·2017
Same author

Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure.

Gene therapy·2015
Same author

Increased gene expression of catecholamine-synthesizing enzymes in adrenal glands contributes to high circulating catecholamines in pigs with tachycardia-induced cardiomyopathy.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2015
Same author

Matrix metalloproteinase 9/neutrophil gelatinase associated lipocalin/tissue inhibitor of metalloproteinasess type 1 complexes are localized within cardiomyocytes and serve as a reservoir of active metalloproteinase in porcine female myocardium.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2014
Same journal

Women, men and heart failure: a review.

Heart failure monitor·2008
Same journal

Anemia and erythropoietin in heart failure.

Heart failure monitor·2008
Same journal

The pharmacological rationale behind polypharmacy in heart failure.

Heart failure monitor·2008
Same journal

Diuretics - a panacea for acute heart failure? Different formulations, doses, and combinations.

Heart failure monitor·2008
Same journal

Congenital heart disease and heart failure.

Heart failure monitor·2008
Same journal

Neuregulin-1 and its potential role in the control of cardiac function.

Heart failure monitor·2008
See all related articles

Heightened chemoreceptor sensitivity in chronic heart failure (CHF) is linked to poor outcomes and increased mortality. Targeting chemoreceptors may offer new therapeutic avenues for CHF patients.

Area of Science:

  • Cardiology
  • Respiratory Medicine
  • Neuroscience

Background:

  • Augmented peripheral and central chemoreceptor sensitivity is observed in chronic heart failure (CHF).
  • Chemoreflexes influence respiratory, circulatory, and neurohormonal systems, impacting CHF pathophysiology.
  • Heightened chemoreflex drive is an ominous sign in CHF, contributing to sympathetic overactivity and abnormal breathing patterns.

Purpose of the Study:

  • To investigate the pathophysiological implications of augmented chemoreceptor sensitivity in CHF.
  • To determine if high chemosensitivity is an independent predictor of mortality in advanced CHF.
  • To explore potential therapeutic strategies targeting chemoreceptors in CHF.

Main Methods:

  • Review of experimental and clinical data on chemoreceptor function in CHF.

Related Experiment Videos

  • Analysis of patient data to correlate chemosensitivity with clinical outcomes.
  • Examination of the effects of interventions like opiates and oxygen on chemosensitivity.

    • Main Results:

    • Elevated chemosensitivity in CHF patients is associated with increased ventilation during exercise, impaired autonomic regulation, and baroreceptor dysfunction.
    • High peripheral chemosensitivity was confirmed as an independent predictor of death in advanced CHF.
    • Opiates and oxygen administration can suppress chemosensitivity, potentially improving exercise tolerance and periodic breathing.

    Conclusions:

    • Augmented chemoreceptor sensitivity is a significant pathophysiological feature of CHF with adverse prognostic implications.
    • High chemosensitivity predicts mortality in advanced CHF patients.
    • Targeting peripheral and central chemoreceptors represents a promising therapeutic strategy for improving CHF prognosis and quality of life.